Literature DB >> 23713608

Evaluation of acute cardiac and chest wall damage after shocks with a subcutaneous implantable cardioverter defibrillator in Swine.

Cheryl R Killingsworth1, Sharon B Melnick, Silvio H Litovsky, Raymond E Ideker, Gregory P Walcott.   

Abstract

BACKGROUND: A subcutaneous implantable cardioverter defibrillator (S-ICD) could ease placement and reduce complications of transvenous ICDs, but requires more energy than transvenous ICDs. Therefore we assessed cardiac and chest wall damage caused by the maximum energy shocks delivered by both types of clinical devices.
METHODS: During sinus rhythm, anesthetized pigs (38 ± 6 kg) received an S-ICD (n = 4) and five 80-Joule (J) shocks, or a transvenous ICD (control, n = 4) and five 35-J shocks. An inactive S-ICD electrode was implanted into the same control pigs to study implant trauma. All animals survived 24 hours. Troponin I and creatine kinase muscle isoenzyme (CK-MM) were measured as indicators of myocardial and skeletal muscle injury. Histopathological injury of heart, lungs, and chest wall was assessed using semiquantitative scoring.
RESULTS: Troponin I was significantly elevated at 4 hours and 24 hours (22.6 ± 16.3 ng/mL and 3.1 ± 1.3 ng/mL; baseline 0.07 ± 0.09 ng/mL) in control pigs but not in S-ICD pigs (0.12 ± 0.11 ng/mL and 0.13 ± 0.13 ng/mL; baseline 0.06 ± 0.03 ng/mL). CK-MM was significantly elevated in S-ICD pigs after shocks (6,544 ± 1,496 U/L and 9,705 ± 6,240 U/L; baseline 704 ± 398 U/L) but not in controls. Electrocardiogram changes occurred postshock in controls but not in S-ICD pigs. The myocardium and lungs were histologically normal in both groups. Subcutaneous injury was greater in S-ICD compared to controls.
CONCLUSION: Although CK-MM suggested more skeletal muscle injury in S-ICD pigs, significant cardiac, lung, and chest wall histopathological changes were not detected in either group. Troponin I data indicate significantly less cardiac injury from 80-J S-ICD shocks than 35-J transvenous shocks. ©2013, The Authors. Journal compilation ©2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  creatine kinase; implantable cardioverter defibrillator; inflammation; swine; troponin I

Mesh:

Year:  2013        PMID: 23713608      PMCID: PMC3796010          DOI: 10.1111/pace.12173

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  18 in total

1.  Effects of repeated electrical defibrillations on cardiac troponin I levels.

Authors:  J A Joglar; D J Kessler; P J Welch; J H Keffer; M E Jessen; M H Hamdan; R L Page
Journal:  Am J Cardiol       Date:  1999-01-15       Impact factor: 2.778

2.  An entirely subcutaneous implantable cardioverter-defibrillator.

Authors:  Gust H Bardy; Warren M Smith; Margaret A Hood; Ian G Crozier; Iain C Melton; Luc Jordaens; Dominic Theuns; Robert E Park; David J Wright; Derek T Connelly; Simon P Fynn; Francis D Murgatroyd; Johannes Sperzel; Jörg Neuzner; Stefan G Spitzer; Andrey V Ardashev; Amo Oduro; Lucas Boersma; Alexander H Maass; Isabelle C Van Gelder; Arthur A Wilde; Pascal F van Dessel; Reinoud E Knops; Craig S Barr; Pierpaolo Lupo; Riccardo Cappato; Andrew A Grace
Journal:  N Engl J Med       Date:  2010-05-12       Impact factor: 91.245

3.  The contradiction of appropriate shocks in primary prevention ICDs: increasing and decreasing the risk of death.

Authors:  Michael O Sweeney
Journal:  Circulation       Date:  2010-12-06       Impact factor: 29.690

4.  An entirely subcutaneous implantable cardioverter–defibrillator.

Authors:  Sebastiaan Kleijn; Astrid van der Veldt
Journal:  N Engl J Med       Date:  2010-10-14       Impact factor: 91.245

5.  Is there a need for routine testing of ICD defibrillation capacity? Results from more than 1000 studies.

Authors:  J Brunn; D Böcker; M Weber; M Castrucci; R Gradaus; M Borggrefe; G Breithardt; M Block
Journal:  Eur Heart J       Date:  2000-01       Impact factor: 29.983

6.  Effects of implantable cardioverter defibrillator implantation and shock application on biochemical markers of myocardial damage.

Authors:  T Schlüter; H Baum; A Plewan; D Neumeier
Journal:  Clin Chem       Date:  2001-03       Impact factor: 8.327

7.  Detection of myocardial injury during transvenous implantation of automatic cardioverter-defibrillators.

Authors:  T M Hurst; M Hinrichs; C Breidenbach; N Katz; B Waldecker
Journal:  J Am Coll Cardiol       Date:  1999-08       Impact factor: 24.094

8.  Transmural recording of shock potential gradient fields, early postshock activations, and refibrillation episodes associated with external defibrillation of long-duration ventricular fibrillation in swine.

Authors:  James D Allred; Cheryl R Killingsworth; J Scott Allison; Derek J Dosdall; Sharon B Melnick; William M Smith; Raymond E Ideker; Gregory P Walcott
Journal:  Heart Rhythm       Date:  2008-08-28       Impact factor: 6.343

9.  Ascending-ramp biphasic waveform has a lower defibrillation threshold and releases less troponin I than a truncated exponential biphasic waveform.

Authors:  Jian Huang; Gregory P Walcott; Richard B Ruse; Scott J Bohanan; Cheryl R Killingsworth; Raymond E Ideker
Journal:  Circulation       Date:  2012-08-03       Impact factor: 29.690

Review 10.  Do clinically relevant transthoracic defibrillation energies cause myocardial damage and dysfunction?

Authors:  Gregory P Walcott; Cheryl R Killingsworth; Raymond E Ideker
Journal:  Resuscitation       Date:  2003-10       Impact factor: 5.262

View more
  9 in total

Review 1.  Initial experience of subcutaneous implantable cardioverter defibrillators in Singapore: a case series and review of the literature.

Authors:  Tien Siang Eric Lim; Boon Yew Tan; Kah Leng Ho; Chuh Yih Paul Lim; Wee Siong Teo; Chi-Keong Ching
Journal:  Singapore Med J       Date:  2015-10       Impact factor: 1.858

2.  Acute Effects of Implantable Cardioverter-Defibrillator Shocks on Biomarkers of Myocardial Injury, Apoptosis, Heart Failure, and Systemic Inflammation.

Authors:  Jordan Brewster; Travis Sexton; Gary Dhaliwal; Richard Charnigo; Gustavo Morales; Kevin Parrott; Yousef Darrat; John Gurley; Susan Smyth; Claude S Elayi
Journal:  Pacing Clin Electrophysiol       Date:  2017-03-08       Impact factor: 1.976

Review 3.  The subcutaneous ICD-current evidence and challenges.

Authors:  Kiran Haresh Kumar Patel; Pier D Lambiase
Journal:  Cardiovasc Diagn Ther       Date:  2014-12

Review 4.  Clinical experience with subcutaneous implantable cardioverter-defibrillators.

Authors:  Geoffrey F Lewis; Michael R Gold
Journal:  Nat Rev Cardiol       Date:  2015-04-21       Impact factor: 32.419

Review 5.  Value of The Wearable Cardioverter Defibrillator (WCD) as a Bridging-Therapy before Implantation of a Cardioverter Defibrillator (ICD).

Authors:  Priv Doz; Johannes Sperzel
Journal:  J Atr Fibrillation       Date:  2016-02-29

6.  Transvenous or subcutaneous implantable cardioverter defibrillator: a review to aid decision-making.

Authors:  Milena Leo; Alexander J Sharp; Andre Briosa E Gala; Michael T B Pope; Timothy R Betts
Journal:  J Interv Card Electrophysiol       Date:  2022-07-14       Impact factor: 1.759

Review 7.  The entirely subcutaneous defibrillator (s-icd): state of the art and selection of the ideal candidate.

Authors:  Elia De Maria; Alina Olaru; Stefano Cappelli
Journal:  Curr Cardiol Rev       Date:  2015

8.  Effects of defibrillation shock in patients implanted with a subcutaneous defibrillator: a biomarker study.

Authors:  Antonio D'Onofrio; Vincenzo Russo; Valter Bianchi; Ciro Cavallaro; Silvia Leonardi; Stefano De Vivo; Filippo Vecchione; Anna Rago; Ernesto Ammendola; Vincenzo Tavoletta; Luigi Atripaldi; Paola Elvira Mocavero; Gerardo Nigro
Journal:  Europace       Date:  2018-09-01       Impact factor: 5.214

9.  Higher Concentration of Hypertonic Saline Shows Better Recovery Effects on Rabbits with Uncontrolled Hemorrhagic Shock.

Authors:  Lei Xu; Fengjuan Kang; Wendong Hu; Xiwen Liu
Journal:  Med Sci Monit       Date:  2019-10-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.